Press Releases

6/10/2008 Javelin Pharmaceuticals Enrolls First Patient in Pivotal Trial for PMI-150	9.9 KB
6/5/2008 Javelin Pharmaceuticals' Founder and President Transitions to Executive Director	7.3 KB
6/4/2008 Javelin Pharmaceuticals, Inc. Announces New Patent Covering PMI-150 (Intranasal Ketamine)	9.3 KB
5/14/2008 Javelin Pharmaceuticals, Inc. Reports First Quarter 2008 Results	12.5 KB
5/9/2008 Javelin Pharmaceuticals to Announce First Quarter 2008 Financial Results	7.5 KB
5/8/2008 Javelin Pharmaceuticals, Inc. to Raise $27.6 Million through Registered Direct Offering	6.7 KB
4/16/2008 Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development	8.5 KB
4/1/2008 Javelin CEO to Present at the 8th Annual Fortis Biotechnology Conference	7.0 KB
3/14/2008 Javelin Pharmaceuticals CEO to Present at Cowen & Company's 28th Annual Health Care Conference	8.0 KB
3/10/2008 Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)	9.7 KB
3/6/2008 Javelin Pharmaceuticals Reports Results for the Year Ended 2007	13.0 KB
3/4/2008 Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer	10.4 KB
2/28/2008 Javelin Pharmaceuticals, Inc. Vice President to Assume Consultant Role	7.6 KB
2/28/2008 Javelin Pharmaceuticals Regains Compliance with Amex Director Independence Rules	8.2 KB
2/25/2008 Javelin Pharmaceuticals Completes Subject Accrual for all Pharmacokinetic Clinical Studies of PMI-150	9.9 KB
2/22/2008 Javelin Pharmaceuticals to Host Year End Conference Call	7.9 KB
2/19/2008 Javelin Pharmaceuticals Names Peter Kiernan to Board of Directors	8.7 KB
1/22/2008 Javelin Pharmaceuticals Expands Patent Protection for PMI-150 in Canada	8.6 KB
1/8/2008 Javelin Pharmaceuticals' Latest Study of Dyloject(TM) Confirms Minimal Effect on Platelet Function, Differentiating Dyloject from Ketorolac and Aspirin	9.6 KB
1/7/2008 Javelin Pharmaceuticals CEO to Present at JPMorgan's 26th Annual Healthcare Conference	7.4 KB
Showing 1-20 of 108 releases Page: 1 2 3 4 5 6  See Next 20

CONTACT US   JOIN US   SITE MAP
© 2008 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.